These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2161451)
1. In vitro and in vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. Beer HF; Bläuenstein PA; Hasler PH; Delaloye B; Riccabona G; Bangerl I; Hunkeler W; Bonetti EP; Pieri L; Richards JG J Nucl Med; 1990 Jun; 31(6):1007-14. PubMed ID: 2161451 [TBL] [Abstract][Full Text] [Related]
2. Imaging benzodiazepine receptors in the human brain by single photon emission computed tomography (SPECT). Höll K; Deisenhammer E; Dauth J; Carmann H; Schubiger PA Int J Rad Appl Instrum B; 1989; 16(8):759-63. PubMed ID: 2559905 [TBL] [Abstract][Full Text] [Related]
3. Radioiodinated 2'-iododiazepam: a potential imaging agent for SPECT investigations of benzodiazepine receptors. Saji H; Iida Y; Nakatsuka I; Kataoka M; Ariyoshi K; Magata Y; Yoshitake A; Yokoyama A J Nucl Med; 1993 Jun; 34(6):932-7. PubMed ID: 8389843 [TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine receptors in chronic cerebrovascular disease: comparison with blood flow and metabolism. Sasaki M; Ichiya Y; Kuwabara Y; Yoshida T; Fukumura T; Masuda K J Nucl Med; 1997 Nov; 38(11):1693-8. PubMed ID: 9374335 [TBL] [Abstract][Full Text] [Related]
6. SPECT imaging of the benzodiazepine receptor in non-human primate brain with [123I]Ro 16-0154. Innis R; Zoghbi S; Johnson E; Woods S; al-Tikriti M; Baldwin R; Seibyl J; Malison R; Zubal G; Charney D Eur J Pharmacol; 1991 Feb; 193(2):249-52. PubMed ID: 1646734 [TBL] [Abstract][Full Text] [Related]
7. [Functional imaging (PET and SPECT) in epilepsy]. Borbély K Orv Hetil; 2001 Nov; 142(44):2405-14. PubMed ID: 11766233 [TBL] [Abstract][Full Text] [Related]
8. [Assessment of cerebral benzodiazepine receptor distribution in epilepsy by 123I-iomazenil-SPECT]. Uchiyama M; Sue H; Fukumitsu N; Mori Y; Kawakami K Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jan; 57(1):47-51. PubMed ID: 9038063 [TBL] [Abstract][Full Text] [Related]
9. SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. Innis RB; al-Tikriti MS; Zoghbi SS; Baldwin RM; Sybirska EH; Laruelle MA; Malison RT; Seibyl JP; Zimmermann RC; Johnson EW J Nucl Med; 1991 Sep; 32(9):1754-61. PubMed ID: 1652627 [TBL] [Abstract][Full Text] [Related]
10. [Phase 1 clinical study of 123I-iomazenil: a new probe to evaluate central-type benzodiazepine receptor with SPECT]. Yonekura Y; Nishizawa S; Tanaka F; Ishizu K; Okazawa H; Fujita T; Konishi J; Torizuka K Kaku Igaku; 1995 Jan; 32(1):87-97. PubMed ID: 7897872 [TBL] [Abstract][Full Text] [Related]
11. Decrease in benzodiazepine receptor binding in a patient with Angelman syndrome detected by iodine-123 iomazenil and single-photon emission tomography. Odano I; Anezaki T; Ohkubo M; Yonekura Y; Onishi Y; Inuzuka T; Takahashi M; Tsuji S Eur J Nucl Med; 1996 May; 23(5):598-604. PubMed ID: 8698070 [TBL] [Abstract][Full Text] [Related]
12. [Benzodiazepine receptor imaging with positron emission tomography and single photon emission tomography]. Bartenstein P; Koepp M Nervenarzt; 1995 Jun; 66(6):412-21. PubMed ID: 7637827 [TBL] [Abstract][Full Text] [Related]